Skip to main content
BFRG
NASDAQ Life Sciences

BullFrog AI Secures 180-Day Nasdaq Extension and Readies Reverse Split to Regain Compliance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.57
Mkt Cap
$10.569M
52W Low
$0.425
52W High
$2.04
52W Position info
34% above low
Off High info
72% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

BFRG sits 34% above its 52-week low of $0.425.

Summary

BullFrog AI received a second 180-day Nasdaq compliance period and plans a reverse stock split if needed to lift its share price above $1.00.


Key Events · Legal and Risk Events · BFRG

  • Second Compliance Period Granted

    Nasdaq extended the deadline to February 8, 2027, giving the company another 180 days to regain the $1.00 minimum bid price.

  • Reverse Split Contingency

    The company notified Nasdaq that it will effect a reverse stock split (ratio 1:2 to 1:15) if the price doesn't recover organically, using stockholder approval from October 2025.

  • Delisting Risk Remains

    If compliance is not regained by February 8, 2027, securities will be subject to delisting, though the company can appeal to a Nasdaq Hearings Panel.

  • Going Concern Backdrop

    The extension comes days after the Q2 10-Q disclosed a going concern warning and limited financing capacity, heightening the stakes of maintaining the listing.


Analysis · BFRG · Life Sciences

Nasdaq has granted BullFrog AI a second 180-day compliance period, extending the deadline to February 8, 2027, after the stock failed to regain the $1.00 minimum bid price. The company has informed Nasdaq that it will pursue a reverse stock split if the price does not recover organically, relying on stockholder approval from October 2025 for a ratio between 1:2 and 1:15. This move is a critical survival step for a company already facing a going concern warning and limited financing capacity.

At the time of this filing, BFRG was trading at $0.57 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.6M. The 52-week trading range was $0.43 to $2.04. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BFRG - Latest Insights

BFRG
Aug 14, 2026, 4:13 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.5891
Real-time Price: $0.5699 info
Change: -$0.0192 (-3%) info
Market Cap: $10.569M info
BFRG
Jul 06, 2026, 4:00 PM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $0.698
Real-time Price: $0.5699 info
Change: -$0.1281 (-18%) info
Market Cap: $10.569M info
BFRG
Jun 15, 2026, 5:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.6387
Real-time Price: $0.5699 info
Change: -$0.0688 (-11%) info
Market Cap: $10.569M info
BFRG
May 29, 2026, 4:34 PM EDT
Filing Type: S-1
Importance Score:
8
Price at Filing: $0.7551
Real-time Price: $0.5699 info
Change: -$0.1852 (-25%) info
Market Cap: $10.569M info
BFRG
May 14, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.602
Real-time Price: $0.5699 info
Change: -$0.0321 (-5%) info
Market Cap: $10.569M info